Saakshi Medtech Board Approves Capital Hike, Preferential Issue & 34.41% Stake Acquisition in Laxmi Engineering

6 min read     Updated on 08 May 2026, 08:09 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Saakshi Medtech & Panels' board, at its May 07, 2026 meeting, approved raising authorised share capital to Rs. 25 crore, a preferential issue of 20,22,940 equity shares at Rs. 207 each aggregating Rs. 41,87,48,580 via share swap to 51 non-promoter allottees, and the acquisition of a 34.41% equity stake in Laxmi Engineering Industries Bhopal Pvt Ltd for INR 41.87 crore. An EGM has been scheduled for June 02, 2026 to seek shareholder approval for these resolutions.

powered bylight_fuzz_icon
39753454

*this image is generated using AI for illustrative purposes only.

The Board of Directors of Saakshi Medtech & Panels , at their meeting held on May 07, 2026, approved a series of significant corporate actions, including an increase in authorised share capital, a preferential allotment of equity shares, and the acquisition of a 34.41% equity stake in Laxmi Engineering Industries Bhopal Pvt Ltd. The decisions were disclosed to the National Stock Exchange of India Limited in compliance with Regulation 30 read with Schedule III, Part A, Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the SEBI master circular dated November 11, 2024.

Authorised Share Capital Increase

The board approved an increase in the authorised share capital of the company, subject to the approval of members at the ensuing Annual General Meeting. The proposed alteration will also result in a consequent change to Clause V of the Memorandum of Association of the company. The details of the existing and proposed capital structure are as follows:

Parameter: Existing Clause Proposed Clause
Authorised Share Capital: Rs. 18,00,00,000/- (Rupees Eighteen Crore) Rs. 25,00,00,000/- (Twenty-Five Crore)
Number of Equity Shares: 1,80,00,000 (One Crore Eighty Lakhs) 2,50,00,000 (Two Crore Fifty Lakhs)
Face Value per Share: Rs. 10/- each Rs. 10/- each

Preferential Issue of Equity Shares

The board approved the issuance of 20,22,940 equity shares of face value Rs. 10 each at an issue price of Rs. 207 per equity share, which includes a premium of Rs. 197 per equity share, aggregating to Rs. 41,87,48,580. The allotment is proposed on a preferential basis to non-promoter investors in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. Notably, the consideration for this issuance is other than cash — specifically, a swap of shares.

The key parameters of the preferential issue are summarised below:

Parameter: Details
Type of Securities: Equity Shares
Type of Issuance: Preferential Issue
Total Shares to be Issued: 20,22,940
Issue Price: Rs. 207/- per equity share
Face Value: Rs. 10/- per equity share
Premium: Rs. 197/- per equity share
Aggregate Amount: Rs. 41,87,48,580/-
Category of Allottees: Non-Promoters
Nature of Consideration: Other than cash (Share Swap)

Proposed Allottees — Shareholding Details

A total of 51 non-promoter allottees are proposed to receive equity shares under the preferential issue. The post-issue shareholding of notable allottees is presented below:

Allottee: Shares to be Allotted Post-Issue Shares Post-Issue %
PRATHAM PRASOON 2,35,870 2,35,870 1.20%
NARESH SARAAF 1,43,720 1,44,920 0.74%
PRAFUL KUMAR 1,69,928 1,69,928 0.86%
SNEHAL BHUPENDRA SHAH 1,69,082 1,69,082 0.86%
LALIT AGRAWAL 83,696 1,16,096 0.59%
SUNIL VITHALRAO CHAVAN 50,725 1,55,725 0.79%
SIDDHARTHA DAGA 76,238 76,238 0.39%
SATYABRATA MOHANTY 50,725 1,02,925 0.52%
JASBIR SINGH CHOUHAN 53,261 55,061 0.28%
SAURABH MEHTA 53,261 53,261 0.27%
Girish Paman Vanvari 50,725 50,725 0.26%
HASTI MEET MEHTA 50,725 50,725 0.26%
HIREN RAJENDRA MEHTA 50,725 50,725 0.26%
HITEN POPATLAL SHAH 50,725 62,725 0.32%
KIRAN I KARNAWAT 50,725 50,725 0.26%
RUPA KISHOR SHAH 50,725 50,725 0.26%
Total (All Allottees): 20,22,940

Acquisition of 34.41% Stake in Laxmi Engineering Industries Bhopal Pvt Ltd

In addition to the capital restructuring actions, the board also approved the acquisition of 34.41% equity shareholding in Laxmi Engineering Industries Bhopal Pvt Ltd ("Target Company") for a total consideration of INR 41.87 crore. The acquisition will be completed through a share swap, wherein Saakshi Medtech & Panels will issue 20,22,940 equity shares against the acquisition of 23,92,850 equity shares of the Target Company. The acquisition will be completed upon the completion of the preferential allotment to the shareholders of the Target Company. No governmental or regulatory approvals are required for this acquisition.

The key details of the acquisition are summarised below:

Parameter: Details
Target Company: Laxmi Engineering Industries Bhopal Pvt Ltd
Stake Acquired: 34.41%
Total Consideration: INR 41.87 Crore
Nature of Consideration: Swap of Shares
Shares Issued by Acquirer: 20,22,940 equity shares
Shares Acquired in Target: 23,92,850 equity shares
Completion Trigger: On completion of preferential allotment
Regulatory Approvals Required: None

About Laxmi Engineering Industries Bhopal Pvt Ltd

Laxmi Engineering Industries Bhopal Pvt Ltd (LEI) is an India-based engineering company engaged in the design, engineering, and manufacturing of customised heat transfer equipment and allied heavy engineering solutions. Its product portfolio includes shell and tube heat exchangers, air-cooled heat exchangers, surface condensers, feed water heaters, pressure vessels, finned tube heat exchangers, deaerators, and other fabricated assemblies used across sectors such as power generation (thermal, hydro, nuclear, and solar), oil & gas, chemicals, fertilisers, cement, sugar, and other industrial process plants. LEI traces its origins to 1987, when it was established as a partnership firm, and was subsequently converted into a private limited company in July 2007. The company is compliant with quality standards such as ISO 9001:2015 and manufactures in accordance with applicable industry codes including ASME guidelines and Indian Boiler Regulations. LEI has established relationships with reputed customers including BHEL, NTPC, GAIL, IOCL, L&T, and Mitsubishi, among others, and has also executed export orders across regions including the Middle East, South Asia, and Eurasia. Its manufacturing facilities are located in Bhopal, Madhya Pradesh.

The last three years' turnover of the Target Company is presented below:

Year: Turnover (Rs. in crore)
2025-26 (Provisional): 20.29
2024-25: 17.80
2023-24: 12.13

The proposed acquisition is described as a strategic investment aimed at expanding Saakshi Medtech & Panels' presence within the broader engineering and industrial ecosystem. While the Target Company's operations are not identical to the company's current business of electrical panels and related systems, both operate within the wider domain of industrial engineering and infrastructure solutions, with overlapping customer segments and project environments.

Extraordinary General Meeting Scheduled

To seek shareholder approval for the aforementioned resolutions, the board approved convening an Extraordinary General Meeting on June 02, 2026, at 03:00 p.m., to be held through Video Conferencing / Other Audio Visual Means (VC/OAVM). The board also approved the draft EGM notice, explanatory statement, calendar of events, and other related documents. The formal notice of the EGM will be shared with shareholders in due course.

Additionally, the board approved the appointment of M/s. Jay Pandya & Associates, Practicing Company Secretary (Membership No. A63213, Certificate of Practice No. 24319), as Scrutinizer for conducting e-voting and providing the requisite report for the resolutions to be passed at the EGM. The disclosures required under Regulation 30 of the Listing Regulations, as detailed in Annexure A and Annexure B, have been submitted to the stock exchange and are also hosted on the company's website.

Historical Stock Returns for Saakshi Medtech & Panels

1 Day5 Days1 Month6 Months1 Year5 Years
+2.74%+14.16%+38.97%+52.63%+85.36%+72.24%

How might Saakshi Medtech & Panels leverage Laxmi Engineering's existing relationships with BHEL, NTPC, and GAIL to cross-sell its electrical panel products and expand its order book?

Given that Saakshi Medtech is acquiring only a 34.41% minority stake in Laxmi Engineering, what is the likelihood of the company pursuing a majority or full acquisition in the future as the strategic partnership matures?

How could the share swap structure of this acquisition impact Saakshi Medtech's earnings per share and existing shareholder value following the dilution from the preferential allotment of 20,22,940 new shares?

Saakshi Medtech & Panels
View Company Insights
View All News
like17
dislike
1 Year Returns:+85.36%